|
|
http://www.oxfordbiomaterials.com
Oxford Biomaterials is a medical devices company founded in 2001 to
develop Spidrex: a novel silk-based absorbable biomaterial for use in
the repair and regeneration of human tissues.
Our unique technology has wide-ranging market appeal and is being
taken up in four separate ventures including cartilage, suturing, and
nerve repair products.
For the past two years, efforts have focussed on the development of our Spidrex Bone Graft Material: SilkBone™ - the world’s first absorbable, load bearing, off-the-shelf Bone Graft Material.
Our unique absorbable product combines mechanical support comparable
to real bone, with a highly porous and hydrophilic structure such that
patient’s own regenerating bone will eventually replace the implant.
http://www.progentix.com
Progentix BV, founded in 2004, is a Dutch life sciences company that
develops an innovative platform technology based on an automated,
closed bioreactor system to expand bone marrow derived adult
mesenchymal stem cells.
This expansion system is
stand-alone, simple-to-operate and does not require a complex
laboratory environment. It can be placed within any hospital
department, and is able to generate over 200 million expanded adult
stem cells.
Adult stem cells can be used in
regenerative medicine to treat various tissue disorders (such as bone
and cartilage defects, cardiovascular disease and central neural system
disorders) and as a screening platform for the discovery of new drugs,
small molecules and genes.
Progentix focuses on the
clinical use of adult stem cells for bone regeneration and for that
reason also develops a unique range of synthetic osteoinductive
biomaterial scaffolds.
http://www.vhfak.slu.se/
SLU
is a sector University working side by side with the larger Uppsala
University. It employs 2500 staff of whom 1000 are academic. Its
research is focussed on the four areas linked to agriculture -
Veterinary Medicine, Agriculture, Forestry and Horticulture. It has
aimed at an international frontline position in modern molecular
biology, microbiology and protein chemistry including advanced
structural biological techniques including x-ray crystallography, NMR
and 3-D molecular modelling. Expertise available at SLU in the field of
orthopaedics medicine and in vivo trials, combined with a leading
molecular-based science program makes SLU an attractive partner in this
proposal.
http://www.som.soton.ac.uk/divisions/FOAD/ortho/
Professor
Richard Oreffo and Dr Helmtrud Roach are part of the Bone and Joint
Research Group based within the RAE 5* rated Division of Foetal Origins
of Adult Disease (FOAD) directed by Professor Hanson and Professor
Barker FRS. The group will shortly become part of the new Centre of
Developmental Origins of Health and Disease. The new building is
located on the Southampton General Hospital site and comprises three
stories with an additional sub-basement and will provide ~2,600 m²
accommodation to house 80 researchers and support staff. Within the
major laboratory complexes will be a dedicated Human Stem Cell and
Developmental Biology Unit and centrally-managed generic facilities for
Molecular Biology; Vascular Biology; Endocrine and Metabolite Analysis;
Tissue Preparation, Microscopy and Image Analysis. The new DOHAD Centre
building has been funded by a £4.5M from the university’s SRIF
allocation with funds from Wolfson Foundation and Weston Foundation
(£5.5M). The centre will bring together a range of staff groups with
multidisciplinary expertise in programming mechanisms associated with
embryos and stem cell; cardiovascular and vascular biology; metabolism
and endocrinology; and mesenchyme and bone development. University
Orthopaedics is also associated with a large clinical facility for
Trauma and Orthopaedics within Southampton University Hospital NHS
Trust. This wealth of equipment, and the know how of the lead
applicants in the field of bone tissue engineering is the reason Soton
have been invited to join the consortium.
http://www.chm.bris.ac.uk/inorg/mann/webpage.htm
Professor
Steve Mann FRS has established an international reputation for work in
self-assembly/templating approaches in materials chemistry. His
research is principally concerned with the chemical synthesis and
characterization of complex forms of organized matter, particularly at
the bioinorganic interface. Specifically, his work has explored the
interface between biomineralization and materials chemistry, from which
he has developed a conceptual framework for the synthetic construction
of higher-order inorganic structures. His work on biomineralization has
pursued a chemical and structural approach to the study of small-scale
functional structures, with particular focus on the synthesis and
assembly of nanoscale magnets in magnetotactic bacteria,
superparamagnetic iron oxides in ferritin protein cages, and complex
chiral architectures in the calcium carbonate coccoliths of certain
marine algae. In parallel, he has pioneered a biomimetic approach to
materials chemistry based on the use of self-assembled organic
structures for the synergistic synthesis of organized inorganic matter.
Prof Mann has published over 300 scientific papers, many of which are
in highly prestigious journals including Science and Nature. The
widespread importance of his work has been recognised in setting up the
Centre for Organized Matter Chemistry of which he is the Director in
the School of Chemistry at UNIVBRIS. The Centre's research activities
are housed in new laboratories and associated with the Electron
Microscopy Facility, which consists of five electron microscopes all
with EDX analysis systems, and are currently housed in a newly
refurbished site with associated laboratory and office space. The
Facility is supported by a full-time electron microscopy research
associate and technician. Full training is provided on the operation of
all the microscopes and associated equipment. Basic specimen
preparation facilities for routine electron microscopy are also
available. Besides the EM facilities, the Centre has full use of a wide
range of facilities required in materials research, including; XRD,
TGA, FTIR, UV/VIS and liquid and solid state NMR spectroscopies, BET,
SAXS, zeta potential analysis, MS, GPC and high temperature furnaces.
In terms of general research and academic infrastructure, the School of
Chemistry at UNIVBRIS is a grade 5* department with 47 members of
staff, and a research community of over 200 postgraduate research
students and postdoctoral research assistants offering training in a
wide variety of distinguished research programmes. Achieving correct
mineralisation of composites is of paramount importance to the
project’s likelihood of success which is why UNIVBRIS were invited to
join the consortium.
http://users.ox.ac.uk/~abrg/ABRGweb.html
UOXF.AT
is one of the world´s oldest universities with an excellent record in
almost every subject area. Over the last 100 years the university has
world lead the world in the fields of zoology, ecology and
developmental biology. UOXF.AT also offers excellent facilities with
respect to studies of protein structure and function and has hosted
leading protein scientists such as Dame Dorothy Hodgkin and Sir David
Phillips. Prof Vollrath's group in UOXF.AT is one of the leading
research laboratories worldwide working on silks and specifically
spider silks. This has been been recognised by the recent award of a
E.U. Training and Mobility grant to his group, which at this moment
consists of 2 Dphil students and 4 senior scientists. Over the last 10
years the group has produced over 100 scientific publications on silk
and attracted research funding from a wide range of sponsors and
organisations. The focus of the research in the group has shifted over
the years generating unique insights into all aspects of silk: from the
chemistry of the spinning feedstocks to the physical details of the
spinning conditions, from analysis of the mechanical properties to the
underlying molecular mechanisms, from the descriptions of silk
mechanics to highly accurate models and simulations. The analytical
tools used by the group range from all levels of microscopy, from FTIR-
and Raman-spectroscopy as well as X-ray diffraction on single
sub-micron fibres to Nuclear Magnetic Resonance on both feedstock and
fibres. In addition the group has several unique stress-strain testers
as well as a dedicated Instron and a micro-rheometer. The insights of
the group and the tools available will range from crucial to very
useful when testing the different materials that the consortium aims to
generate. Prof Vollrath’s unrivalled knowledge of arthropod silks and
their mechanical properties is the central reason for UOXF.AT’s
partnership.
http://www.3hbiomedical.com
3H
Biomedical AB is an innovative life-science company that develops
market-driven products and testing for cell research, the cell-based
tissue engineering market and therapeutic vaccine market. 3H Biomedical
AB began to operate in April 2004. Dr. Mallen Huang and Dr. Anders Gobl
are the founders of the company. 3H Biomedical have extensive expertise
in the areas of cell and tissue culture, including: Stem cells, EPCs,
Mesenchymal stem cells, Immune cells, Primary cell culture, Cell
transplantation, Gene-modification of primary cells, Immunology, and
Molecular Biology, as well as the formulation of therapeutic vaccines
for the treatment and prevention of cancer and other diseases. 3H
biomedical also has access to Hyaluronic Gel Technology.
U Kon InPuT at the University of Konstanz, is an organisational unit
of Steinbeis GmbH founded by the Federal State of Baden-Württemberg,
Germany. U Kon InPuT develops, adapts, employs and validates a spectrum
of meaningful in vitro and ex vivo test systems of animal and human
origin. Since U Kon InPuT was founded in 1995 it has conducted more
than 90 contracts with companies in eight countries. U Kon InPuT
co-ordinated a validation study within the EU 5th Framework Programme,
participated in two more FP5 shared cost actions and has carried out
several direct contracts with the European Centre for the Validation of
Alternative Methods (ECVAM) at the Joint Research Centre in Ispra,
Italy. U Kon InPuT is part of an integrated project in FP6.
The
group focuses on in vitro alternatives to animal experiments. Models
are developed or taken over from academic research. After
standardisation and optimisation, an evaluation and (pre-)validation is
carried out. For this purpose, U Kon InPuT organises and participates
in collaborative studies. U Kon InPuT will be responsible for
assessment of in vitro immunological effects and biocompatibility
testing as well as quality control issues as the leader of WP 6. U Kon
InPuT will interact and give feedback to all other preclinical
workpackages, aiming to optimize the developed materials to minimize
the need for animal experiments. All of the technology and expertise
required for its tasks are well established. U Kon InPuT will benefit
from the proposed project by further expanding its applications of the
In vitro Pyrogen Test in the field of biomaterial testing.
The
team leader, Dr. Sonja von Aulock, is building up her own subgroup and
currently ha 3 Ph. D. students, a post-doc and two diploma students
within the subgroup of Prof. Thomas Hartung who will also take a lead
role in the project. She is involved in the Graduate School ‘Biomedical
Drug Research’, holds lectures in the cycles ‘Human Biology’ and
‘Biomedicine’, and is the scientific leader of the Marie Curie Research
Training Network Pulmo-Net. As a representative of U Kon InPuT, she is
involved in the management of the FP5 project ‘Spiderman’. Thomas
Hartung, (M.D.Ph.D.) obtained his PhD in pharmacology (University of
Konstanz) on an inflammatory liver cell model, and is an MD in
Toxicology (University of Tübingen) on metabolism of xenobiotics. He
has developed two in vitro alternatives to animal experiments which are
currently being validated in co-operation with industry and national
authorities. He has been awarded three prizes for research on replacing
animal experiments (German Ministry of Health 1993, F.I.S.E.A.
Luxembourg 1993, Doerenkamp-Zbinden Award 1996) and one in pharmacology
(Sandoz 1995).
|